Strategies to evaluate outcomes in long-COVID-19 and post-COVID survivors
Genre
Journal articleDate
2021-10-30Author
Crispo, AnnaBimonte, Sabrina
Porciello, Giuseppe
Forte, Cira Antonietta
Cuomo, Gaia
Montagnese, Concetta
Prete, Melania
Grimaldi, Maria
Celentano, Egidio
Amore, Alfonso
de Blasio, Elvio
Pentimalli, Francesca
Giordano, Antonio
Botti, Gerardo
Baglio, Giovanni
Sileri, Pierpaolo
Cascella, Marco
Cuomo, Arturo
Group
Center for Biotechnology, Sbarro Institute for Cancer Research and Molecular Medicine (Temple University)Department
BiologyPermanent link to this record
http://hdl.handle.net/20.500.12613/7591
Metadata
Show full item recordDOI
https://doi.org/10.1186/s13027-021-00401-3Abstract
SARS-CoV-2 infection can impact the physical, cognitive, mental health of patients, especially in those recovered in intensive care units. Moreover, it was proved that the effects of the virus may persist for weeks or months. The term long-COVID or post-COVID syndrome is commonly used for indicating a variety of physical and psychological symptoms that continue after the resolution of the acute phase. This narrative review is aimed at providing an updated overview of the impact of physical, cognitive, and psychological health disorders in COVID-19 survivors, by summarizing the data already published in literature in the last year. Studies cited were found through PubMed searches. We also presented an overview of the post-COVID-19 health consequences on three important aspects: nutritional status, neurological disorders, and physical health. Moreover, to activate a correct health planning policy, a multidisciplinary approach for addressing the post- COVID-19 issue, has been proposed. Finally, the involvement of health professionals is necessary even after the pandemic, to reduce expected post-pandemic psychosocial responses and mental health disorders.Citation
Crispo, A., Bimonte, S., Porciello, G. et al. Strategies to evaluate outcomes in long-COVID-19 and post-COVID survivors. Infect Agents Cancer 16, 62 (2021). https://doi.org/10.1186/s13027-021-00401-3Citation to related work
BMCHas part
Infectious Agents and Cancer, Vol. 16ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.eduae974a485f413a2113503eed53cd6c53
http://dx.doi.org/10.34944/dspace/7569